When Health Defines the Season: Sarr, Lively and the NBA's Young Big Man Foot Problem

I spent an entire month rewinding preseason tape. Not to find the strongest team — that's a job for June. I was looking for the answer to a different question, more practical and far crueler: which team will still have enough healthy bodies on the floor by the end of October. The result made me sit up straight in my chair. The NBA's 2026-26 season is opening with a foot crisis. Alex Sarr and Dereck Lively II, two young centers cast as the future cornerstones of two entirely different franchises, are both dealing with foot problems right as the season prepares to tip off. The whole basketball world is talking about their potential. I'm talking about something far less glamorous: whether they'll still be standing in November.

This isn't the first time I've bet on something the majority doesn't want to hear. In 2026, I claimed on my podcast that Wang Shang should start ahead of a foreign league top scorer, and the entire internet called me insane. When that kid scored four goals in five games at season's end, my podcast listens jumped from 3,000 to 50,000 overnight. The whole village cursed me over an unknown kid — wait until I finish telling the story. This time I'm not telling the story of an unknown player. I'm telling the story of a generation of young big men being betrayed by their own feet.

The Big Picture

Over the past few days, I've spent time rereading pre-season injury updates — the kind of material anyone in my line of work must know by heart like a multiplication table. The aggregated brief in my hands paints a far more worrying picture than the glossy headlines usually reflect.

Alex Sarr, center for the Washington Wizards, is described as a "partial participant" in training camp — a phrase I want to pause on and dissect. He's only taking part in a portion of full-team work. Behind that technical-sounding phrase lies an overlapping injury history: Sarr underwent right-foot surgery back in June, and has also missed games with left big-toe capsulitis. Two injury timelines, two different body parts, but both on the feet of a 6-foot-11 player still developing physically.

Dereck Lively II of the Dallas Mavericks is even more concerning. Last season, he played exactly seven games before December surgery ended his season. As of now, Lively has still not been confirmed as ready for full training camp work. For a center with a prior foot injury history, slow recovery is not a small detail.

And Jalen Williams of the Oklahoma City Thunder, the second star on a team that just reached the Western Conference Finals, carries a hamstring injury history on both legs. A right-side injury cost him most of last season. Then came the left hamstring, flaring during the playoffs. Bilateral hamstring issues in a player at the prime of his career is a signal anyone monitoring player health has to pause on.

Three names. Three problems. One season. And this is where I place my bet.

Sarr and the Pretty Number Without a Foundation

Let's start with the number everyone is quoting. Last season, Alex Sarr averaged 16.3 points, 7.4 rebounds, 2.7 assists, 0.8 steals and 2.0 blocks in 27.2 minutes per game. On that spread of numbers alone, anyone has the right to get excited. A 6-foot-11 center scoring 16 points, nearly 2 blocks per game, and even initiating offense with almost 3 assists — that's the modern big-man archetype the entire league is hunting for.

But here's where I diverge from most people covering this. I need the second number to balance the first. In the brief I read, not a single efficiency metric accompanies those totals. No TS% — true shooting. No eFG%. No PER. No EPM. No on/off splits. No impact metric to confirm that those 16.3 points were scored in a context that actually matters competitively.

This is what over a decade in this business has taught me, and what three mispronunciations of Mbappé's name — one month of silently rewinding tape without words — burned into me: every number needs another number to lean against. A center scoring 16 points on a rebuilding team where the ball is funneled into his hands because there's no one else will look identical to a rising star. But context is what separates a real star from a pretty stat line. The Washington Wizards were a bottom-tier team last season, and any player given free rein with the ball there will accumulate attractive numbers.

Hold on — I'm not saying Sarr is a fraud. I'm saying something else, and I want to say it clearly: that 2.0 blocks in 27 minutes is an elite rim-protection rate. I've watched enough of his tape to state that confidently. What I object to is hyping a player on half the data. When you bet on a young center as a future cornerstone, you need to know how accurately he shoots, how he impacts both ends, and most importantly — whether he's available to play.

And that's where the story turns dark.

The truth is, what's shaping this season isn't the skill of young centers, but their ability to keep their feet intact.

The Foot — a Big Man's Eternal Enemy

There's a line in the brief I read over and over: foot injuries in big men are not something to toy with. People invoke Yao Ming, Joel Embiid, and a whole generation of centers whose careers were swallowed by their feet. A 6-foot-11 player's feet bear load many times greater than a 6-foot-3 guard's. Every jump, every change of direction, every landing drives force into an anatomical structure never designed to carry such a massive body through 82 games.

This is why I view Sarr's season with skepticism. He's 22 — an age that should be his most vigorous, when the body can endure and recover fastest. But he's already had right-foot surgery in June, and a history of left big-toe capsulitis. Two problems in two different feet on one body that hasn't fully matured.

If you're a Washington fan, what does this mean? It means all your calculations about the team's future should rest on one question: whether Sarr can play 70 games in a season. And if you do the job I do, that question becomes the axis of an entire column.

I remember once, after I dissected a young player and his fans came after me relentlessly, I sat alone and read every public medical report on him. I found I'd been wrong on one timing detail. Just one. But it changed my entire conclusion. Since then, I've set a rule for myself: when analyzing injuries, I must publicly acknowledge what I don't know. In Sarr's case, I don't know whether the June surgery and the toe capsulitis are two independent injuries or signs of a larger structural issue. I only know both exist, and both are in his feet.

Lively and Dallas: A Problem With No Plan B

If Sarr's story is a question of potential, Dereck Lively II's story is a far more competitively serious problem. The Dallas Mavericks enter the season with a center who played exactly seven games last season before December surgery ended his year. Seven games. That's not a small sample — it's practically no sample at all.

With Lively, any evaluation of skill becomes meaningless. A player who doesn't play can't show his talent. And the brief I read issues a clear warning: Dallas shouldn't rush him back. In professional basketball, bringing a player back too early from a foot injury is a recipe for recurrence, and recurrent foot injuries usually mean a longer stay on the operating table.

For Dallas, this changes everything. The team has a fallback named Daniel Gafford — a center good enough to start at an acceptable level. Gafford doesn't raise Dallas's ceiling, but he keeps the floor from collapsing. The problem is that when you have to lean on Plan B for months, you lose what top-tier teams treat as a weapon: the ability to change a game's rhythm off the bench.

In a season where the Western Conference is already suffocatingly crowded, losing a promising young center — or even just losing certainty about his status — can be the difference between a direct playoff berth and a play-in slot. And the teams understand that very well.

Jalen Williams and the Blow to the Hamstring

Oklahoma City just came off a season that reached the Western Conference Finals. They are one of the youngest, most exciting and best-organized teams in the league. But when you dissect their roster, one detail stands out worryingly: Jalen Williams, the second star beside Shai Gilgeous-Alexander, carries a hamstring injury history on both legs.

A right hamstring issue cost him most of last season. Then came the left hamstring in the playoffs. For a player of Williams's age and caliber, bilateral hamstring problems are something every team medical staff must put on the red-watch list. The hamstring is the muscle group responsible for acceleration and deceleration — the burst Williams needs to create separation. When both sides have issues, the risk of recurrence under competitive load rises significantly.

And this is where I bet on caution. In the brief, Oklahoma City's general manager is quoted describing Williams as "fantastic" right now. I believe he's sincere. But I wonder something anyone in this business should wonder: what is a compliment in September, with zero official games played, actually worth?

Hamstring injuries don't recur during light practices. They recur when a player has to sprint in the 38th minute of his fourth game in five nights. They recur when the body is tired and the mind is tense. No September press conference can forecast that.

I learned this lesson the hardest way, when I mispronounced Mbappé's name three times on national television and then spent a whole month rewinding tape to understand where I went wrong. One month of silently rewinding tape taught me more than a decade of loudly asserting. And what it taught me is this: pre-season declarations, no matter whose mouth they come from, are only hypotheses until proven by real games.

Oklahoma City and the Three-Guard Gamble

But Oklahoma City's story doesn't stop at Williams. The team is preparing to expand minutes for a group of young guards: Cason Wallace, Ajay Mitchell and Jared McCain. This is a genuine tactical shift, not just routine rotation.

Cason Wallace has had two steady seasons and is on the threshold of a leap. Ajay Mitchell was an interesting find last season. And Jared McCain — a first-round pick — brings a scoring-guard mold the Thunder haven't had on the roster. Expanding roles for this trio reflects a philosophy: after losing a perimeter player, the team chooses to reinvest in pace and spacing rather than rushing into the trade market for a replacement.

This is the Sam Presti model — a general manager rated among the league's best. He builds through the draft and internal development, and never buys outside when he can grow his own. But there's a downside I want to point out: when you bet on internal development, you accept a risk premium. Three young guards competing for shared minutes means each gets less opportunity to prove himself, and pressure to convert every minute into production rises.

In that context, the detail that Luguentz Dort is said to have moved to Atlanta made me pause. Dort has been tied to Oklahoma City's defensive identity for years. If the team genuinely lost him, then expanding minutes for three young guards is no longer planned innovation but a reactive fix. That's a big difference in tactical intent. Still, I must be clear: this detail sits among internally contradictory information in the brief I read, so I don't place full trust in it. If I'm wrong, I'll say I'm wrong — as I always do.

Vukcevic and Opportunity Born of Another Man's Pain

Back to Washington. With Sarr only partially participating in training camp, the door opens for Tristan Vukcevic — another young center on the roster. During Sarr's absence or limited availability, Vukcevic gets a starting audition. And here's what I want you to notice: these are starting spots created by another man's injury, and they are live auditions.

Vukcevic fits the stretch-big mold — a player who can shoot threes and pull opposing defenders out of the paint. On a rebuilding team, a stretch big who shows capability quickly gains trade value and contract value. If Vukcevic seizes this opportunity, he doesn't just help Washington tread water while Sarr is out — he re-prices his own future.

This is the cruel face of professional basketball I want readers to look straight at. One player's pain is another's opportunity, and on rebuilding teams these opportunities appear more often than on championship-aspiring ones. That doesn't mean anyone celebrates a teammate's injury. It means that in a league where every roster spot is an asset, the vacuum always gets filled, and whoever fills it best keeps the spot.

Small Details Reflecting Big Vision

There's one detail in the brief I consider more important than it looks: Washington may sit Julian Reese for some games to preserve a slot in his two-way contract allotment.

To the average fan, this is a boring technical detail. To me, it's a sign of an organization that understands the rules at the operational level. Two-way contracts stipulate a player can only be active for a limited number of NBA game days before conversion to a standard contract is required. A team actively managing this allotment shows it's optimizing consciously — balancing playing time, cost and roster flexibility.

For Washington, a team in a rebuilding phase, managing assets so meticulously reflects sound thinking: while you wait for a star like Sarr to get healthy, you still have to run the organization professionally in every small detail. That's why I read details like this closely, instead of just staring at scoring numbers.

The Contrarian Angle: Where I Could Be Wrong

Now it's time to interrogate myself. Because a bold bettor who never questions himself is a con man — someone selling certainty to people who don't know we're all guessing.

The first place I could be wrong: I might be exaggerating the severity of these injuries. Pre-season is a period where every negative piece of information is inflated and every positive one is doubted. Maybe by mid-October, Sarr is playing full games, Lively is cleared, and Williams is sprinting as if nothing ever happened. In that case, I'd be the guy who spread needless worry, a sin I've committed before and had to publicly correct.

The second place I could be wrong: I might be underestimating teams' ability to manage injuries. Modern sports medicine has advanced enormously. Foot surgeries that might have ended careers twenty years ago now often cost only part of a season. If teams have good load-management plans, the problem may stay small.

And the third, most serious: the brief I rely on contains internal contradictions I must publicly acknowledge. It describes Sarr as part of an interior duo with a Dallas star — impossible given roster reality. It places Dort in Atlanta, contradicting his decade with Oklahoma City. And it blends two different injury timelines for Sarr. These contradictions reduce the reliability of any individual fact, and I must humbly admit that part of my analytical foundation sits on ground that isn't entirely firm.

This matters, and I want to say it clearly: I'm not betting that every detail in the brief is correct. I'm betting on a larger trend it reflects — that the NBA is entering a season where the availability of young big men is the most important variable, and that teams are managing information about it strategically.

How Teams Control the Narrative

There's one detail I've saved for the end. Throughout the brief, almost every commentary on player status comes from general managers, not head coaches. This is a deliberate framing choice. When the GM delivers injury and role news, the coach stays out of the firing line — the man on the bench isn't publicly accountable for rotation decisions and can focus on his professional work.

For Washington, this is especially true at a moment when Sarr's image is the organization's biggest asset. A GM describing his player as progressing positively reassures fans, protects the asset's value, and avoids pressure to bring him back too soon.

For Oklahoma City, stability and message discipline reflect a mature organization. Sam Presti never overstates. He praises his young players just enough to raise internal expectations without creating a promise the team can't keep. That's an art, and it's why Oklahoma City, despite not having the flashiest star, remains among the most respected organizations.

What to Watch

If you follow this season like I do, here are the signals I'll be watching, and I suggest you watch them too.

First, Sarr's level of camp participation. Any report upgrading him from "partial participant" to "full participant" is a positive signal, and any delay is a negative one. The best way to track it is to read beat reporters covering the team, not aggregated briefs.

Second, Lively's confirmed status. If Dallas confirms he's cleared for contact, the team's ceiling rises. If not, Daniel Gafford will carry the starter role for a long stretch, and that changes how Dallas can deploy its lineups.

Third, Sarr's efficiency metrics once the season begins. The 16.3 points and 2.0 blocks need verification through TS%, PER or EPM. If those metrics confirm it, Sarr is genuinely on a max-contract trajectory. If not, we're looking at a product of ball concentration on a bad team.

Fourth, how OKC allocates minutes to its three young guards. If any of Cason Wallace, Ajay Mitchell or Jared McCain plays over 28 minutes a game, that's a sign a genuine leap is happening.

And fifth, Jalen Williams's hamstring under real competitive load. Any missed game in a back-to-back would confirm the recurrence concern.

Takeaway

This whole story brings me back to a thought I can't push out of my head. Over more than a decade covering this sport, I've watched so many talents swallowed not by lack of skill, but by a body that couldn't hold up. Basketball is a sport of tall people challenging the biological limits of their own bodies, and sometimes biology wins.

If I'm right — and I could be wrong — the NBA's 2026-26 season will be remembered not for who scored the most points, but for who kept their feet intact through 82 games. And for people like Alex Sarr, Dereck Lively II and Jalen Williams, the question is no longer whether they have talent. The question is whether their bodies will allow that talent to be seen.

I'll be the first to say I was wrong, if December arrives and all three are playing the best basketball of their careers. But until then, I'm keeping my vote. And I'm placing it on one simple belief: in professional basketball, availability isn't a property of talent. It's the foundation on which every other talent is built.

Wait until the October tape drops. Then we'll know which of us prepared for a season of feet no longer whole.